Sagility Q2 FY25 results (Jul–Sep 2024) and concall

Sagility India delivered a strong performance in its first earnings call as a listed entity, characterized by 21.1% YoY revenue growth and industry-leading margins. The company is successfully leveraging its deep domain expertise in the U.S. Healthcare market, particularly within the Payer segment. Management is focused on a dual strategy of mining existing large accounts while aggressively targeting the mid-market to diversify its client base and reduce concentration.